Treatment of esophageal varices: a randomized controlled trial comparing endoscopic sclerotherapy and EUS-guided sclerotherapy of esophageal collateral veins

Background Endoscopic sclerotherapy (ES) and band ligation are standard treatments for esophageal varices. Unfortunately, recurrence is common and seems to be related to esophageal collateral vessels, easily identified by EUS. Eradication of these vessels might lead to a more durable therapeutic eff...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastrointestinal endoscopy 2006-03, Vol.63 (3), p.396-402
Hauptverfasser: Andrade de Paulo, Gustavo, MD, PhD, Ardengh, José Celso, MD, PhD, Nakao, Frank Shigueo, MD, Ferrari, Angelo Paulo, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 402
container_issue 3
container_start_page 396
container_title Gastrointestinal endoscopy
container_volume 63
creator Andrade de Paulo, Gustavo, MD, PhD
Ardengh, José Celso, MD, PhD
Nakao, Frank Shigueo, MD
Ferrari, Angelo Paulo, MD, PhD
description Background Endoscopic sclerotherapy (ES) and band ligation are standard treatments for esophageal varices. Unfortunately, recurrence is common and seems to be related to esophageal collateral vessels, easily identified by EUS. Eradication of these vessels might lead to a more durable therapeutic effect. Objective To compare ES with EUS-guided sclerotherapy of collateral vessels (EUS-ES). Design Randomized controlled trial. Setting Endoscopy unit, Division of Gastroenterology. Universidade Federal de São Paulo, São Paulo, Brazil. Patients and Interventions Fifty cirrhotic patients with esophageal varices were randomized into 2 groups: ES (n = 25) and EUS-ES (n = 25). EUS-ES was targeted at collateral veins. Patients were followed-up for at least 6 months after eradication. Main Outcome Measurements Efficacy in eradication, complications, and recurrence of varices. Results Varices were eradicated in 48 patients who adhered to the study protocol. The mean (SD) number of sessions until eradication was 4.3 (1.5) for the ES group and 4.1 (1.2) for the EUS-ES group. In ES group, 4 patients had mild bleeding. In EUS-ES group, 4 patients had pain. The mean (SD) length of the follow-up period was 22.6 (6.9) months for the ES group and 24.9 (8.1) months for the EUS-ES group. Recurrence was seen in 4 patients after ES and in 2 after EUS-ES ( P = .32). The presence of collateral vessels was associated with recurrence ( P = .003). Limitations Not applicable. Conclusion EUS-ES is as safe and effective as ES in variceal eradication. Recurrence tends to be less frequent and occurs later. Persistence of esophageal collateral vessels after sclerotherapy is a risk factor for recurrence.
doi_str_mv 10.1016/j.gie.2005.10.039
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67691220</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016510705031639</els_id><sourcerecordid>67691220</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-9774a185f88332d1c518081bec2a419ffba2f8f0b2bd3165d5fbbcabb35a0f283</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhi0EokvhB3BBvsAty9he5wMkJFSVD6kSh7Zny3HGWy9JHOxspeW_8F-ZaFeqyoGTP-Z5Z8bzmrHXAtYCRPl-t94GXEsATec1qOYJWwloqqKsquYpWwFBhRZQnbEXOe8AoJZKPGdnotQAqi5X7M9NQjsPOM48eo45Tnd2i7bn9zYFh_kDtzzZsYtD-I0dd3GcU-x72s4pEObiMBE5bjkSlF2cguPZ9ZjifIfJTgdOan55e11s96Ej3ePg46KOUtuZIlQfw5hfsmfe9hlfndZzdvvl8ubiW3H14-v3i89Xhduoci6aqtpYUWtf10rJTjgtaqhFi07ajWi8b630tYdWtp2it3fat62zbau0BS9rdc7eHfNOKf7aY57NELJDambEuM-mrMpGSAkEiiPoUsw5oTdTCoNNByPALJ6YnSFPzOLJckWekObNKfm-HbB7UJxMIODtCbDZ2d7TvF3ID1ylG6GFIu7jkUMaxX3AZLILODrsQkI3my6G_7bx6R-168MYqOBPPGDexX0aacZGmCwNmOvl8yx_BzTQzCjBX4mCwrE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67691220</pqid></control><display><type>article</type><title>Treatment of esophageal varices: a randomized controlled trial comparing endoscopic sclerotherapy and EUS-guided sclerotherapy of esophageal collateral veins</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Andrade de Paulo, Gustavo, MD, PhD ; Ardengh, José Celso, MD, PhD ; Nakao, Frank Shigueo, MD ; Ferrari, Angelo Paulo, MD, PhD</creator><creatorcontrib>Andrade de Paulo, Gustavo, MD, PhD ; Ardengh, José Celso, MD, PhD ; Nakao, Frank Shigueo, MD ; Ferrari, Angelo Paulo, MD, PhD</creatorcontrib><description>Background Endoscopic sclerotherapy (ES) and band ligation are standard treatments for esophageal varices. Unfortunately, recurrence is common and seems to be related to esophageal collateral vessels, easily identified by EUS. Eradication of these vessels might lead to a more durable therapeutic effect. Objective To compare ES with EUS-guided sclerotherapy of collateral vessels (EUS-ES). Design Randomized controlled trial. Setting Endoscopy unit, Division of Gastroenterology. Universidade Federal de São Paulo, São Paulo, Brazil. Patients and Interventions Fifty cirrhotic patients with esophageal varices were randomized into 2 groups: ES (n = 25) and EUS-ES (n = 25). EUS-ES was targeted at collateral veins. Patients were followed-up for at least 6 months after eradication. Main Outcome Measurements Efficacy in eradication, complications, and recurrence of varices. Results Varices were eradicated in 48 patients who adhered to the study protocol. The mean (SD) number of sessions until eradication was 4.3 (1.5) for the ES group and 4.1 (1.2) for the EUS-ES group. In ES group, 4 patients had mild bleeding. In EUS-ES group, 4 patients had pain. The mean (SD) length of the follow-up period was 22.6 (6.9) months for the ES group and 24.9 (8.1) months for the EUS-ES group. Recurrence was seen in 4 patients after ES and in 2 after EUS-ES ( P = .32). The presence of collateral vessels was associated with recurrence ( P = .003). Limitations Not applicable. Conclusion EUS-ES is as safe and effective as ES in variceal eradication. Recurrence tends to be less frequent and occurs later. Persistence of esophageal collateral vessels after sclerotherapy is a risk factor for recurrence.</description><identifier>ISSN: 0016-5107</identifier><identifier>EISSN: 1097-6779</identifier><identifier>DOI: 10.1016/j.gie.2005.10.039</identifier><identifier>PMID: 16500386</identifier><identifier>CODEN: GAENBQ</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adult ; Biological and medical sciences ; Collateral Circulation ; Digestive system. Abdomen ; Disease-Free Survival ; Endoscopy ; Endosonography ; Esophageal and Gastric Varices - diagnostic imaging ; Esophageal and Gastric Varices - pathology ; Esophageal and Gastric Varices - therapy ; Esophagoscopy ; Female ; Follow-Up Studies ; Gastroenterology and Hepatology ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Other diseases. Semiology ; Recurrence ; Sclerotherapy - methods ; Treatment Outcome</subject><ispartof>Gastrointestinal endoscopy, 2006-03, Vol.63 (3), p.396-402</ispartof><rights>American Society for Gastrointestinal Endoscopy</rights><rights>2006 American Society for Gastrointestinal Endoscopy</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-9774a185f88332d1c518081bec2a419ffba2f8f0b2bd3165d5fbbcabb35a0f283</citedby><cites>FETCH-LOGICAL-c436t-9774a185f88332d1c518081bec2a419ffba2f8f0b2bd3165d5fbbcabb35a0f283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0016510705031639$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17591513$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16500386$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Andrade de Paulo, Gustavo, MD, PhD</creatorcontrib><creatorcontrib>Ardengh, José Celso, MD, PhD</creatorcontrib><creatorcontrib>Nakao, Frank Shigueo, MD</creatorcontrib><creatorcontrib>Ferrari, Angelo Paulo, MD, PhD</creatorcontrib><title>Treatment of esophageal varices: a randomized controlled trial comparing endoscopic sclerotherapy and EUS-guided sclerotherapy of esophageal collateral veins</title><title>Gastrointestinal endoscopy</title><addtitle>Gastrointest Endosc</addtitle><description>Background Endoscopic sclerotherapy (ES) and band ligation are standard treatments for esophageal varices. Unfortunately, recurrence is common and seems to be related to esophageal collateral vessels, easily identified by EUS. Eradication of these vessels might lead to a more durable therapeutic effect. Objective To compare ES with EUS-guided sclerotherapy of collateral vessels (EUS-ES). Design Randomized controlled trial. Setting Endoscopy unit, Division of Gastroenterology. Universidade Federal de São Paulo, São Paulo, Brazil. Patients and Interventions Fifty cirrhotic patients with esophageal varices were randomized into 2 groups: ES (n = 25) and EUS-ES (n = 25). EUS-ES was targeted at collateral veins. Patients were followed-up for at least 6 months after eradication. Main Outcome Measurements Efficacy in eradication, complications, and recurrence of varices. Results Varices were eradicated in 48 patients who adhered to the study protocol. The mean (SD) number of sessions until eradication was 4.3 (1.5) for the ES group and 4.1 (1.2) for the EUS-ES group. In ES group, 4 patients had mild bleeding. In EUS-ES group, 4 patients had pain. The mean (SD) length of the follow-up period was 22.6 (6.9) months for the ES group and 24.9 (8.1) months for the EUS-ES group. Recurrence was seen in 4 patients after ES and in 2 after EUS-ES ( P = .32). The presence of collateral vessels was associated with recurrence ( P = .003). Limitations Not applicable. Conclusion EUS-ES is as safe and effective as ES in variceal eradication. Recurrence tends to be less frequent and occurs later. Persistence of esophageal collateral vessels after sclerotherapy is a risk factor for recurrence.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Collateral Circulation</subject><subject>Digestive system. Abdomen</subject><subject>Disease-Free Survival</subject><subject>Endoscopy</subject><subject>Endosonography</subject><subject>Esophageal and Gastric Varices - diagnostic imaging</subject><subject>Esophageal and Gastric Varices - pathology</subject><subject>Esophageal and Gastric Varices - therapy</subject><subject>Esophagoscopy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastroenterology and Hepatology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Other diseases. Semiology</subject><subject>Recurrence</subject><subject>Sclerotherapy - methods</subject><subject>Treatment Outcome</subject><issn>0016-5107</issn><issn>1097-6779</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kk1v1DAQhi0EokvhB3BBvsAty9he5wMkJFSVD6kSh7Zny3HGWy9JHOxspeW_8F-ZaFeqyoGTP-Z5Z8bzmrHXAtYCRPl-t94GXEsATec1qOYJWwloqqKsquYpWwFBhRZQnbEXOe8AoJZKPGdnotQAqi5X7M9NQjsPOM48eo45Tnd2i7bn9zYFh_kDtzzZsYtD-I0dd3GcU-x72s4pEObiMBE5bjkSlF2cguPZ9ZjifIfJTgdOan55e11s96Ej3ePg46KOUtuZIlQfw5hfsmfe9hlfndZzdvvl8ubiW3H14-v3i89Xhduoci6aqtpYUWtf10rJTjgtaqhFi07ajWi8b630tYdWtp2it3fat62zbau0BS9rdc7eHfNOKf7aY57NELJDambEuM-mrMpGSAkEiiPoUsw5oTdTCoNNByPALJ6YnSFPzOLJckWekObNKfm-HbB7UJxMIODtCbDZ2d7TvF3ID1ylG6GFIu7jkUMaxX3AZLILODrsQkI3my6G_7bx6R-168MYqOBPPGDexX0aacZGmCwNmOvl8yx_BzTQzCjBX4mCwrE</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>Andrade de Paulo, Gustavo, MD, PhD</creator><creator>Ardengh, José Celso, MD, PhD</creator><creator>Nakao, Frank Shigueo, MD</creator><creator>Ferrari, Angelo Paulo, MD, PhD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060301</creationdate><title>Treatment of esophageal varices: a randomized controlled trial comparing endoscopic sclerotherapy and EUS-guided sclerotherapy of esophageal collateral veins</title><author>Andrade de Paulo, Gustavo, MD, PhD ; Ardengh, José Celso, MD, PhD ; Nakao, Frank Shigueo, MD ; Ferrari, Angelo Paulo, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-9774a185f88332d1c518081bec2a419ffba2f8f0b2bd3165d5fbbcabb35a0f283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Collateral Circulation</topic><topic>Digestive system. Abdomen</topic><topic>Disease-Free Survival</topic><topic>Endoscopy</topic><topic>Endosonography</topic><topic>Esophageal and Gastric Varices - diagnostic imaging</topic><topic>Esophageal and Gastric Varices - pathology</topic><topic>Esophageal and Gastric Varices - therapy</topic><topic>Esophagoscopy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastroenterology and Hepatology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Other diseases. Semiology</topic><topic>Recurrence</topic><topic>Sclerotherapy - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andrade de Paulo, Gustavo, MD, PhD</creatorcontrib><creatorcontrib>Ardengh, José Celso, MD, PhD</creatorcontrib><creatorcontrib>Nakao, Frank Shigueo, MD</creatorcontrib><creatorcontrib>Ferrari, Angelo Paulo, MD, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastrointestinal endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andrade de Paulo, Gustavo, MD, PhD</au><au>Ardengh, José Celso, MD, PhD</au><au>Nakao, Frank Shigueo, MD</au><au>Ferrari, Angelo Paulo, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of esophageal varices: a randomized controlled trial comparing endoscopic sclerotherapy and EUS-guided sclerotherapy of esophageal collateral veins</atitle><jtitle>Gastrointestinal endoscopy</jtitle><addtitle>Gastrointest Endosc</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>63</volume><issue>3</issue><spage>396</spage><epage>402</epage><pages>396-402</pages><issn>0016-5107</issn><eissn>1097-6779</eissn><coden>GAENBQ</coden><abstract>Background Endoscopic sclerotherapy (ES) and band ligation are standard treatments for esophageal varices. Unfortunately, recurrence is common and seems to be related to esophageal collateral vessels, easily identified by EUS. Eradication of these vessels might lead to a more durable therapeutic effect. Objective To compare ES with EUS-guided sclerotherapy of collateral vessels (EUS-ES). Design Randomized controlled trial. Setting Endoscopy unit, Division of Gastroenterology. Universidade Federal de São Paulo, São Paulo, Brazil. Patients and Interventions Fifty cirrhotic patients with esophageal varices were randomized into 2 groups: ES (n = 25) and EUS-ES (n = 25). EUS-ES was targeted at collateral veins. Patients were followed-up for at least 6 months after eradication. Main Outcome Measurements Efficacy in eradication, complications, and recurrence of varices. Results Varices were eradicated in 48 patients who adhered to the study protocol. The mean (SD) number of sessions until eradication was 4.3 (1.5) for the ES group and 4.1 (1.2) for the EUS-ES group. In ES group, 4 patients had mild bleeding. In EUS-ES group, 4 patients had pain. The mean (SD) length of the follow-up period was 22.6 (6.9) months for the ES group and 24.9 (8.1) months for the EUS-ES group. Recurrence was seen in 4 patients after ES and in 2 after EUS-ES ( P = .32). The presence of collateral vessels was associated with recurrence ( P = .003). Limitations Not applicable. Conclusion EUS-ES is as safe and effective as ES in variceal eradication. Recurrence tends to be less frequent and occurs later. Persistence of esophageal collateral vessels after sclerotherapy is a risk factor for recurrence.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>16500386</pmid><doi>10.1016/j.gie.2005.10.039</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0016-5107
ispartof Gastrointestinal endoscopy, 2006-03, Vol.63 (3), p.396-402
issn 0016-5107
1097-6779
language eng
recordid cdi_proquest_miscellaneous_67691220
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Biological and medical sciences
Collateral Circulation
Digestive system. Abdomen
Disease-Free Survival
Endoscopy
Endosonography
Esophageal and Gastric Varices - diagnostic imaging
Esophageal and Gastric Varices - pathology
Esophageal and Gastric Varices - therapy
Esophagoscopy
Female
Follow-Up Studies
Gastroenterology and Hepatology
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Investigative techniques, diagnostic techniques (general aspects)
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Other diseases. Semiology
Recurrence
Sclerotherapy - methods
Treatment Outcome
title Treatment of esophageal varices: a randomized controlled trial comparing endoscopic sclerotherapy and EUS-guided sclerotherapy of esophageal collateral veins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T10%3A53%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20esophageal%20varices:%20a%20randomized%20controlled%20trial%20comparing%20endoscopic%20sclerotherapy%20and%20EUS-guided%20sclerotherapy%20of%20esophageal%20collateral%20veins&rft.jtitle=Gastrointestinal%20endoscopy&rft.au=Andrade%20de%20Paulo,%20Gustavo,%20MD,%20PhD&rft.date=2006-03-01&rft.volume=63&rft.issue=3&rft.spage=396&rft.epage=402&rft.pages=396-402&rft.issn=0016-5107&rft.eissn=1097-6779&rft.coden=GAENBQ&rft_id=info:doi/10.1016/j.gie.2005.10.039&rft_dat=%3Cproquest_cross%3E67691220%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67691220&rft_id=info:pmid/16500386&rft_els_id=S0016510705031639&rfr_iscdi=true